Hi Mac9
This from Morgan’s;
Investment view▪ We continue to view ANP as one of the best risk / reward plays in the space and while short-term market risks have increased, the long-term rewards remain unchanged at this stage. Speculative Buy retained.▪ We remain buyers on further weakness for long-term
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-21
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.001(1.37%) |
Mkt cap ! $66.71M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 7.4¢ | 7.3¢ | $3.483K | 47.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 228996 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.4¢ | 12961 | 1 |
View Market Depth
| Last trade - 12.48pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.4¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.4¢ | 7.4¢ | 7.4¢ | 6740 | ||
| Last updated 13.35pm 16/05/2024 ? | |||||
| PER (ASX) Chart |